Relationship between serum bilirubin and uric acid to oxidative stress markers in Italian and Czech populations

Journal of Applied Biomedicine

Volumn 11, Issue 4, 2013, Pages 209-221

  Vítek, Libor ^a   Novotný, Ladislav ^a   Žák, Aleš ^a   Staňková, Barbora ^a   Zima, Tomáš ^a   Polito, Angela ^b   Cesare, Greco ^c   Zerbinati, Chiara ^c   Iuliano, Luigi ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bilirubin; Mediterranean diet; Oxidative stress; Oxysterols; Uric acid

Indexed keywords

7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; BILIRUBIN; BIOLOGICAL MARKER; PEROXY RADICAL; URIC ACID;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; COMPARATIVE STUDY; CZECH REPUBLIC; FEMALE; HUMAN; HUMAN EXPERIMENT; INCIDENCE; ISCHEMIC HEART DISEASE; ITALY; MALE; MEDITERRANEAN DIET; MIDDLE AGED; NORMAL HUMAN; OXIDATIVE STRESS; URIC ACID BLOOD LEVEL; YOUNG ADULT;

EID: 84892156452     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.2478/v10136-012-0030-y     Document Type: Article

References (42)

1. Alkazemi D, Egeland G, Vaya J., Meltzer S, Kubow S. Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J Clin Endocrinol Metab. 93: 4282-4289, 2008.
2. Bach-Faig A., Berry EM, Lairon D, Reguant J., Trichopoulou A, Dernini S, Medina F.X., Battino M., Belahsen R, Miranda G, Serra-Majem L; Mediterranean Diet Foundation Expert Group. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 14: 2274-2284, 2011.
3. Beevers DG, Lip GY Is uric acid really an independent cardiovascular risk factor? Lancet. 352: 1556, 1998.
4. Binkin N, Fontana G, Lamberti A., Cattaneo C, Baglio G, Perra A., Spinelli A. A national survey of the prevalence of childhood overweight and obesity in Italy. Obes Rev. 11: 2-10, 2010.
5. Bjorkhem I, Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol. 22: 734-742, 2002.
6. Boon AC, Hawkins CL, Bisht K, Coombes J.S., Bakrania B., Wagner KH, Bulmer AC Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome. Free Rad Biol Med. 52: 2120-2127, 2012.
7. Bulmer AC, Blanchfield JT, Toth I, Fassett R.G., Coombes JS Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protection. Atherosclerosis. 199: 390-396, 2008.
8. Cifkova R, Skodova Z, Bruthans J., Adamkova V, Jozifova M, Galovcova M., Wohlfahrt P, Krajcoviechova A, Poledne R, Stavek P, Lanska V. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis. 211: 676-681, 2010.
9. Frei B, Stocker R, Ames BN Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA. 85: 9748-9752, 1988.
10. Gagliardi AC, Miname MH, Santos RD Uric acid: A marker of increased cardiovascular risk. Atherosclerosis. 202: 11-17, 2009.
11. Gelissen IC, Brown AJ, Mander E.L., Kritharides L., Dean RT, Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem. 271: 17852-17860, 1996.
12. Gopinathan V, Miller NJ, Milner A.D., Rice Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett. 349: 197-200, 1994.
13. Grau M, Guxens M, Subirana I., Fito M, Covas MI, Jacquemin B, Sunyer J., Lanki T, Picciotto S, Bellander T, Katsouyanni K, Schneider A, Peters A, Marrugat J. South-to-North gradient in lipid peroxidation in men with stable coronary artery disease in Europe. Eur Heart J. 28: 2841-2849, 2007.
14. Hammerman C, Goldstein R, Kaplan M., Eran M, Goldschmidt D, Eidelman A.I., Gartner LM. Bilirubin in the premature: Toxic waste or natural defense? Clin Chem. 44: 2551-2553, 1998.
15. Horsfall LJ, Rait G, Walters K., Swallow DM, Pereira SP, Nazareth I, Petersen I. Serum bilirubin and risk of respiratory disease and death. J Am Med Assoc. 305: 691-697, 2011.
16. Iribarren C, Folsom AR, Eckfeldt J.H., McGovern PG, Nieto FJ Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol. 6: 331-340, 1996.
17. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids. 36 Suppl: S41-S44, 2001.
18. Iuliano L. Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem Phys Lipids. 164: 457-468, 2011.
19. Iuliano L, Piccheri C, Coppola I., Pratico D, Micheletta F, Violi F. Fluorescence quenching of dipyridamole associated to peroxyl radical scavenging: a versatile probe to measure the chain breaking antioxidant activity of biomolecules. Biochim Biophys Acta. 1474: 177-182, 2000.
20. Iuliano L, Micheletta F, Natoli S., Ginanni C, Iappelli M, Elisei W., Giovannelli L, Violi F, Diczfalusy U. Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal Biochem. 312: 217-223, 2003.
21. Jirásková A, Novotný J, Novotný L, Vodicka P, Pardini B, Naccarati A, Schwertner HA, Hubácek JA, Puncochá rová L, Šmerhovský Z, Vítek L. Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer. 131: 1549-1555, 2012.
22. Kafatos A, Diacatou A, Voukiklaris G., Nikolakakis N, Vlachonikolis J, Kounali D., Mamalakis G, Dontas AS. Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 y: the Seven Countries Study. Am J Clin Nutr. 65: 1882-1886, 1997.
23. Keys A, Menotti A, Karvonen M.J., Aravanis C., Blackburn H, Buzina R, Djordjevic B.S., Dontas AS, Fidanza F, Keys MH et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 124: 903-915, 1986.
24. Lanti M, Menotti A, Nedeljkovic S., Nissinen A, Kafatos A, Kromhout D. Long-term trends in major cardiovascular risk factors in cohorts of aging men in the European cohorts of the Seven Countries Study. Aging Clin Exp Res. 17: 306-315, 2005.
25. Larsson H, Bottiger Y, Iuliano L., Diczfalusy U. In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radic Biol Med. 43: 695-701, 2007.
26. Lin JP, Vitek L, Schwertner HA Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease. Clin Chem. 56: 1535-1543, 2010.
27. Maruhashi T, Soga J, Fujimura N., Idei N, Mikami S, Iwamoto Y., Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A et al. Hyperbilirubinemia, augmentation of endothelial function and decrease in oxidative stress in Gilbert syndrome. Circulation. 126: 598-603, 2012.
28. Menotti A, Lanti M, Puddu P.E., Kromhout D. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 84: 238-244, 2000.
29. Micheletta F, Natoli S, Misuraca M., Sbarigia E, Diczfalusy U, Iuliano L. Vitamin e supplementation in patients with carotid atherosclerosis - Reversal of altered oxidative stress status in plasma but not in plaque. Arterioscl Thromb Vasc Biol. 24: 136-140, 2004.
30. Nieto FJ, Iribarren C, Gross M.D., Comstock GW, Cutler RG Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 148: 131-139, 2000.
31. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 228: 568-571, 2003.
32. Stocker R, Keaney JF Role of oxidative modifications in atherosclerosis. Physiol Rev. 84: 1381-1478, 2004.
33. Tapan S, Karadurmus N, Dogru T., Ercin CN, Tasci I, Bilgi C, Kurt I., Erbil MK. Decreased small dense LDL levels in Gilbert's syndrome. Clin Biochem. 44: 300-303, 2011.
34. Traber MG, Jialal I. Measurement of lipid-soluble vitamins - further adjustment needed? Lancet. 355: 2013-2014, 2000.
35. Trichopoulou A, Costacou T, Bamia C., Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 348: 2599-2608, 2003.
36. Tsimikas S, Mallat Z, Talmud P.J., Kastelein JJ, Wareham NJ, Sandhu MS, Miller E.R., Benessiano J., Tedgui A, Witztum JL, Khaw KT, Boekholdt SM. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events. J Am Coll Cardiol. 56: 946-955, 2010.
37. Vejux A, Lizard G. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med. 30: 153-170, 2009.
38. Vitek L, Schwertner HA The heme catabolic pathway and its protective effects on oxidative stressmediated diseases. Adv Clin Chem. 43: 1-57, 2007.
39. Vitek L, Jirsa M, Brodanova M., Kalab M, Marecek Z, Danzig V., Novotny L, Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 160: 449-456, 2002.
40. Yano K, Reed DM, Mcgee DL 10-Year Incidence of Coronary Heart-Disease in the Honolulu Heart Program - Relationship to Biologic and Lifestyle Characteristics. Am J Epidemiol. 119: 653-666, 1984.
41. Yeum KJ, Russell RM, Krinsky N.I., Aldini G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys. 430: 97-103, 2004.
42. Zucker SD, Horn PS, Sherman KE Serum bilirubin levels in the US population: Gender effect and inverse correlation with colorectal cancer. Hepatology. 40: 827-835, 2004.